A manuscript currently under submission from our laboratory supports this assumption, demonstrating the long-term beneficial effects of GLP-1 analogue treatment in patients with psoriasis undergoing systemic therapy (Olbrich et al, submitted). This evidence concerns the gene GCG and psoriasis.